Moolec Science (MLEC) Other Non Operating Income (2022 - 2024)
Moolec Science (MLEC) reported Other Non Operating Income of $608520.0 for Q4 2024, up 594.44% on a YoY basis from $87627.2 in Q1 2024, and down 15.2% sequentially from $717573.0 in Q3 2024.
Moolec Science (MLEC) Other Non Operating Income (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Other Non Operating Income data on file, last reported at $608520.0 in Q4 2024.
- For the quarter ending Q4 2024, Other Non Operating Income rose 594.44% year-over-year to $608520.0; the trailing twelve-month figure through Dec 2024 stood at $2.8 million (up 54.8% YoY), and the FY2024 full-year result was $1.9 million, up 81.36% from the prior year.
- Other Non Operating Income slipped to $608520.0 in Q4 2024, from $717573.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.3 million in Q2 2023 to a low of -$313384.0 in Q4 2022.
- A 3-year average of $423168.5 and a median of $436336.5 in 2023 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income soared 18134.07% in 2023 and plunged 75.28% in 2024, its largest moves.
- Tracing MLEC's Other Non Operating Income over 3 years: stood at -$313384.0 in 2022, then soared by 60.73% to -$123072.0 in 2023, then surged by 594.44% to $608520.0 in 2024.
- Business Quant data shows MLEC's Other Non Operating Income at $608520.0 in Q4 2024, $717573.0 in Q3 2024, and $311633.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 608,520.00 |
| Sep 30, 2024 | 717,573.00 |
| Jun 30, 2024 | 311,633.00 |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | -123,072.00 |
| Sep 30, 2023 | 561,040.00 |
| Jun 30, 2023 | 1.26 Mn |
| Mar 31, 2023 | 86,120.00 |
| Dec 31, 2022 | -313,384.00 |
| Sep 30, 2022 | -3,111.00 |